East Ocyon Bio is a biotechnology company focused on harnessing the power of natural killer (NK) cells for cancer treatment. It specializes in developing cell and gene therapies that modify NK cells using synthetic biology and non-viral cell engineering. The company's innovative approach creates an allogeneic chimeric antigen receptor (CAR) that targets both solid and blood-based tumors, enhancing the immune system's response and tumor recognition. This provides healthcare professionals with advanced treatment options for diverse cancer types.
Swipha
Acquisition in 2024
Swiss Pharma Nigeria (Swipha) manufactures, markets, and distributes pharmaceutical products that meet international standards.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.